5(0I)JL,Boher JM,Genier J. Cyfra21-1,neuron specific enolase and prognosis of lion-sroall cell lung cancer:prospective study in 621 patients[J].Lung Cancer,2001,(2-3):221.doi:10.1016/S0169-5002(00)00186-0.
8Lee JH,Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen,neuroll-specific enolase,and eytokeratin 19 fragments in patients with effusions from pIiI Ila lung callcer[J].Chest,2005,(04):2298-2303.doi:10.1378/chest.128.4.2298.
7Alatas F,Alatas O,Metintas M,et al.Diagnostic value of CEA,CA15-3,CA19-9,CYFRA21-1,NSE and TSA assay in pleural effusions[J].Lung Cancer,2001,31(1):9.
8Cioffi M,Vietri MT,Cazzerro P,et al.Serum anti-p53 antibodies in lung cancer:comparison with established tumor markers[J].Lung Cancer,2001,33(2-3):163.
9Karnak D,Ulubay G.Kayacan O.et al.Evaluation of Cyfra 21-1:a potential tumor marker for non-small cell lung carcinomas[J].Lung,2001,179(1):57.
10Pujol JL,Boher JM,Genier J,et al.Cyfra21-1,neuron specific enolase and prognosis of non-small cell lung cancer:prospective study in 621 patients[J].Lung Cancer,2001,31(2-3):221.
